Biotech · Private company
Miltenyi Biomedicine GmbH
Track this companyFree. Adds Miltenyi Biomedicine GmbH to your Dealase workspace and tells you when its record changes.
Clinical trials119 recruiting or active
Pipeline programs9From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline9
- BendamustinePhase 2 · Refractory Diffuse Large B Cell Lymphoma (DLBCL)ClinicalTrials.gov · fetched Nov 12, 2026
- CyclophosphamidePhase 2 · Refractory Diffuse Large B Cell Lymphoma (DLBCL)ClinicalTrials.gov · fetched Nov 12, 2026
- FludarabinePhase 2 · Refractory Diffuse Large B Cell Lymphoma (DLBCL)ClinicalTrials.gov · fetched Nov 12, 2026
- zamtocabtagene autoleucel (MB-CART2019.1)Phase 2 · Refractory Diffuse Large B Cell Lymphoma (DLBCL)ClinicalTrials.gov · fetched Nov 12, 2026
- CyclophosphamidePhase 1 · Lupus NephritisClinicalTrials.gov · fetched Nov 12, 2026
- FludarabinePhase 1 · Lupus NephritisClinicalTrials.gov · fetched Nov 12, 2026
- zamtocabtagene autoleucelPhase 1 · Lupus NephritisClinicalTrials.gov · fetched Nov 12, 2026
- CliniMACS Prodigy® LP-TCRα/β-19-45RA (Trial Version)Hematological MalignanciesClinicalTrials.gov · fetched Nov 12, 2026
- Long-term Follow-UpNon Hodgkin LymphomaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials11
- M-2018-334 in Hematological MalignanciesNA · RECRUITING · started Aug 21, 2026ClinicalTrials.gov NCT06225050 · fetched Nov 12, 2026
- PRAISE-IR Versus CIBMTR ControlsNOT_YET_RECRUITING · started Jul 31, 2026ClinicalTrials.gov NCT07717164 · fetched Nov 12, 2026
- US Zamto-cel Autoimmune DiseasesPHASE1 · RECRUITING · started Jul 1, 2026ClinicalTrials.gov NCT06708845 · fetched Nov 12, 2026
- Prophylactic TCRaB+ and CD19+ Depleted Donor Lymphocyte Infusion After Allogeneic Stem Cell Transplant in High-Risk Patients With Hematologic MalignanciesNA · RECRUITING · started Feb 26, 2026ClinicalTrials.gov NCT07285668 · fetched Nov 12, 2026
- A Study of MB-CART19.1 Cellular Therapy for People With Central Nervous System Lymphoma (CNSL)PHASE1 · RECRUITING · started Aug 14, 2025ClinicalTrials.gov NCT07137494 · fetched Nov 12, 2026
- Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFURECRUITING · started May 15, 2024ClinicalTrials.gov NCT06116110 · fetched Nov 12, 2026
- DALY II USA/ MB-CART2019.1 for DLBCLPHASE2 · RECRUITING · started May 25, 2021ClinicalTrials.gov NCT04792489 · fetched Nov 12, 2026
- CIML NK Cell in Head & Neck CancerPHASE1 · COMPLETED · started Jul 20, 2020ClinicalTrials.gov NCT04290546 · fetched Nov 12, 2026
- Haploidentical Stem Cell Transplant with Prophylactic Natural Killer DLI for Lymphoma, Multiple Myeloma, and CLLPHASE1 · COMPLETED · started Jul 18, 2018ClinicalTrials.gov NCT03524235 · fetched Nov 12, 2026
- Trial of Regulatory T-cells Plus Low-Dose Interleukin-2 for Steroid-Refractory Chronic Graft-versus-Host-DiseasePHASE1 · ACTIVE_NOT_RECRUITING · started Nov 1, 2013ClinicalTrials.gov NCT01937468 · fetched Nov 12, 2026
- Haplo T-Cell Depleted Transplantation in High-Risk Sickle Cell DiseasePHASE2 · ACTIVE_NOT_RECRUITING · started Jan 1, 2012ClinicalTrials.gov NCT01461837 · fetched Nov 12, 2026